塞栓療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

塞栓療法市場の世界需要は、2023年の48億7,000万米ドルから2032年には106億8,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは9.12%です。

塞栓療法は、塞栓剤を導入することによって血管を閉塞し、血管の状態を治療するために用いられる医療技術です。この低侵襲的手技は、コイル、粒子、または液体薬剤を血管に注入し、標的部位への血流を遮断または減少させる。子宮筋腫、ある種の腫瘍、動静脈奇形などの状態を管理します。この医療技術は、血液供給を選択的に遮断することで、異常な増殖を縮小または除去し、出血を減らし、症状を緩和することを目的としています。この手技は、塞栓物質を正確に送達するために画像誘導を使用します。従来の手術よりも低侵襲で、回復時間の短縮や合併症のリスクの低減などの利点があり、現代のインターベンショナル・ラジオロジーにおける貴重な資産となっています。

市場力学

塞栓療法市場は、子宮筋腫、動静脈奇形（AVM）、特定の腫瘍など、塞栓療法が適応となる疾患の有病率の増加により拡大しています。これらの疾患の罹患率の上昇と、効果的な治療オプションとしての塞栓療法の認知度の高まりが市場の成長を後押ししています。技術的進歩は市場に大きな機会を提供します。より効果的で生体適合性の高い材料の開発を含む塞栓剤の技術革新は、治療成績を向上させ、塞栓療法で対処できる疾患の範囲を拡大します。リアルタイムの透視や3D画像のような高度な画像技術は、塞栓療法の精度と安全性をさらに向上させ、採用を後押ししています。

低侵襲治療への動向も市場成長に寄与しています。塞栓療法は従来の外科的アプローチに比べて侵襲性が低く、回復時間の短縮や合併症発生率の低下につながります。患者の嗜好が低侵襲な選択肢にシフトするにつれて、塞栓療法に対する需要は高まると予想されます。さらに、新興市場におけるヘルスケアアクセスの拡大は成長機会をもたらします。これらの地域ではヘルスケアインフラが改善し、インターベンショナルラジオロジー技術の認知度が高まるにつれて、先進治療へのアクセス向上と医療投資の増加により、塞栓療法の採用が増加すると考えられます。しかし、高コストと潜在的な手技リスクが市場成長を抑制する可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、塞栓療法の世界市場における各セグメントを包括的に評価することもできます。塞栓療法産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

本セクションでは、塞栓療法市場レポートにおける国別および地域別セグメントに関する詳細なデータを提供することで、戦略家がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

製品別

• 塞栓剤
• 微小球
• 塞栓コイル（着脱式コイル、プッシャブルコイル）
• 液体塞栓剤
• 塞栓プラグシステム
• バルーン
• サポートデバイス
• マイクロカテーテル
• ガイドワイヤー

適応疾患別

• がん
• 肝臓がん
• 腎臓がん
• その他のがん
• 末梢血管疾患
• 神経疾患
• 脳動脈瘤
• 脳動静脈奇形および瘻孔
• 消化器疾患
• 泌尿器および腎臓疾患

手技別分析

• 経カテーテル動脈塞栓術
• 経カテーテル動脈ラジオ塞栓術/選択的体内放射線療法
• 経動脈的化学塞栓療法

エンドユーザー別分析

• 病院および診療所
• 外来手術センター
• その他のエンドユーザー

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける塞栓療法市場の現在および将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 塞栓療法- 産業分析

• イントロダクション-市場力学
• 市場促進要因
• 市場抑制要因
• 機会
• 業界動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 塞栓療法の世界市場分析：製品別

• 製品別概要
• 製品別の過去および予測データ分析
• 塞栓剤
• 微小球
• 塞栓用コイル（脱着式コイル、プッシャブルコイル）
• 液体塞栓剤
• 塞栓プラグシステム
• バルーン
• サポートデバイス
• マイクロカテーテル
• ガイドワイヤー

第6章 塞栓療法の世界市場分析：適応疾患別

• 適応疾患別の概要
• 適応疾患別の過去および予測データ分析
• がん
• 肝がん
• 腎臓がん
• その他のがん
• 末梢血管疾患
• 神経疾患
• 脳動脈瘤
• 脳動静脈奇形および瘻孔
• 消化器疾患
• 泌尿器および腎臓疾患

第7章 世界の塞栓療法市場分析：手技別分析

• 概要手技別分析
• 過去および予測データ分析手技別分析
• 経カテーテル動脈塞栓術
• 経カテーテル動脈放射線塞栓療法／選択的内部放射線療法
• 経動脈的化学塞栓療法

第8章 塞栓療法の世界市場分析：エンドユーザー別分析

• エンドユーザー別分析の概要
• 過去および予測データ分析エンドユーザー別分析
• 病院および診療所
• 外来手術センター
• その他のエンドユーザー

第9章 塞栓療法の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州セグメント別
  • 欧州国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋セグメント別
  • アジア太平洋国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカセグメント別
  • ラテンアメリカ国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカセグメント別
  • 中東・アフリカ国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ

第10章 塞栓療法企業の競合情勢

• 塞栓療法市場の競合
• 提携・協力・合意
• 合併・買収
• 新製品発売
• その他の開発

第11章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Merit Medical Systems
• Boston Scientific Corporation
• Medtronic Plc
• Meril Life Sciences Pvt. Ltd

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Embolic agents Market Sales By Geography (USD MN)
• Microspheres Market Sales By Geography (USD MN)
• Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
• Liquid Embolic Agents Market Sales By Geography (USD MN)
• Embolic Plug Systems Market Sales By Geography (USD MN)
• Detachable Balloons Market Sales By Geography (USD MN)
• Support Devices Market Sales By Geography (USD MN)
• Microcatheters Market Sales By Geography (USD MN)
• Guidewires Market Sales By Geography (USD MN)
• Analysis By Disease Indication (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Liver Cancer Market Sales By Geography (USD MN)
• Kidney Cancer Market Sales By Geography (USD MN)
• Other Cancers Market Sales By Geography (USD MN)
• Peripheral Vascular Diseases Market Sales By Geography (USD MN)
• Neurological Diseases Market Sales By Geography (USD MN)
• Cerebral Aneurysm Market Sales By Geography (USD MN)
• Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
• Gastrointestinal Disorders Market Sales By Geography (USD MN)
• Urological and Nephrological Disorders Market Sales By Geography (USD MN)
• Analysis By Procedure Analysis (USD MN)
• Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
• Transarterial Chemoembolization Market Sales By Geography (USD MN)
• Analysis By End User Analysis (USD MN)
• Hospitals and Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Other End Users Market Sales By Geography (USD MN)
• Global Embolotherapy Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Embolotherapy Report
• Market Research Process
• Market Research Methodology
• Global Embolotherapy Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Disease Indication
• Market Attractiveness Analysis By Procedure Analysis
• Market Attractiveness Analysis By End User Analysis
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Embolic agents Market Sales By Geography (USD MN)
• Microspheres Market Sales By Geography (USD MN)
• Embolic coils (Detachable Coils, Pushable Coils) Market Sales By Geography (USD MN)
• Liquid Embolic Agents Market Sales By Geography (USD MN)
• Embolic Plug Systems Market Sales By Geography (USD MN)
• Detachable Balloons Market Sales By Geography (USD MN)
• Support Devices Market Sales By Geography (USD MN)
• Microcatheters Market Sales By Geography (USD MN)
• Guidewires Market Sales By Geography (USD MN)
• Global Market Analysis By Disease Indication (USD MN)
• Cancer Market Sales By Geography (USD MN)
• Liver Cancer Market Sales By Geography (USD MN)
• Kidney Cancer Market Sales By Geography (USD MN)
• Other Cancers Market Sales By Geography (USD MN)
• Peripheral Vascular Diseases Market Sales By Geography (USD MN)
• Neurological Diseases Market Sales By Geography (USD MN)
• Cerebral Aneurysm Market Sales By Geography (USD MN)
• Cerebral Arteriovenous Malformations and Fistulas Market Sales By Geography (USD MN)
• Gastrointestinal Disorders Market Sales By Geography (USD MN)
• Urological and Nephrological Disorders Market Sales By Geography (USD MN)
• Global Market Analysis By Procedure Analysis (USD MN)
• Transcatheter Arterial Embolization Market Sales By Geography (USD MN)
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Market Sales By Geography (USD MN)
• Transarterial Chemoembolization Market Sales By Geography (USD MN)
• Global Market Analysis By End User Analysis (USD MN)
• Hospitals and Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Other End Users Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Embolotherapy Market is presumed to reach the market size of nearly USD 10.68 Billion by 2032 from USD 4.87 Billion in 2023 with a CAGR of 9.12% under the study period 2024-2032.

Embolotherapy is a medical technique used to occlude blood vessels and treat vascular conditions by introducing embolic agents. This minimally invasive procedure involves injecting coils, particles, or liquid agents into blood vessels to block or reduce blood flow to targeted areas. It manages conditions like uterine fibroids, certain types of tumors, and arteriovenous malformations. This medical technique aims to shrink or eliminate abnormal growths, reduce bleeding, and alleviate symptoms by selectively blocking the blood supply. This technique uses imaging guidance to ensure precise delivery of the embolic material. It provides a less invasive option than traditional surgery, offering advantages like shorter recovery time and a lower risk of complications, making it a valuable asset in contemporary interventional radiology.

MARKET DYNAMICS

The embolotherapy market is expanding due to the increasing prevalence of conditions amenable to embolotherapy, such as uterine fibroids, arteriovenous malformations (AVMs), and certain tumors. The rising incidence of these conditions and the growing awareness of embolotherapy as an effective treatment option fuel market growth. Technological advancements provide substantial opportunities for the market. Innovations in embolic agents, including developing more effective and biocompatible materials, enhance treatment outcomes and expand the range of conditions that can be addressed through embolotherapy. Advanced imaging technologies, such as real-time fluoroscopy and 3D imaging, further improve the precision and safety of embolotherapy procedures, driving adoption.

The trend towards minimally invasive treatments is also contributing to market growth. Embolotherapy offers a less invasive alternative to traditional surgical approaches, leading to reduced recovery times and lower complication rates. As patient preference shifts towards minimally invasive options, the demand for embolotherapy procedures is expected to rise. Additionally, expanding healthcare access in emerging markets presents growth opportunities. As healthcare infrastructure improves and awareness of interventional radiology techniques increases in these regions, adopting embolo therapy is likely to grow, driven by enhanced access to advanced treatments and increasing healthcare investment. However, high costs and potential procedural risks can restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolotherapy. The growth and trends of Embolotherapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolotherapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Embolic agents
• Microspheres
• Embolic coils (Detachable Coils, Pushable Coils)
• Liquid Embolic Agents
• Embolic Plug Systems
• Detachable Balloons
• Support Devices
• Microcatheters
• Guidewires

By Disease Indication

• Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancers
• Peripheral Vascular Diseases
• Neurological Diseases
• Cerebral Aneurysm
• Cerebral Arteriovenous Malformations and Fistulas
• Gastrointestinal Disorders
• Urological and Nephrological Disorders

By Procedure Analysis

• Transcatheter Arterial Embolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transarterial Chemoembolization

By End User Analysis

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolotherapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolotherapy market include Merit Medical Systems, Boston Scientific Corporation, Medtronic Plc, Meril Life Sciences Pvt. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. EMBOLOTHERAPY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By Procedure Analysis
  • 3.7.4 Market Attractiveness Analysis By End User Analysis
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Embolic agents Historic and Forecast Sales By Regions
• 5.4. Microspheres Historic and Forecast Sales By Regions
• 5.5. Embolic coils (Detachable Coils, Pushable Coils) Historic and Forecast Sales By Regions
• 5.6. Liquid Embolic Agents Historic and Forecast Sales By Regions
• 5.7. Embolic Plug Systems Historic and Forecast Sales By Regions
• 5.8. Detachable Balloons Historic and Forecast Sales By Regions
• 5.9. Support Devices Historic and Forecast Sales By Regions
• 5.10. Microcatheters Historic and Forecast Sales By Regions
• 5.11. Guidewires Historic and Forecast Sales By Regions

6. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY DISEASE INDICATION

• 6.1. Overview By Disease Indication
• 6.2. Historical and Forecast Data Analysis By Disease Indication
• 6.3. Cancer Historic and Forecast Sales By Regions
• 6.4. Liver Cancer Historic and Forecast Sales By Regions
• 6.5. Kidney Cancer Historic and Forecast Sales By Regions
• 6.6. Other Cancers Historic and Forecast Sales By Regions
• 6.7. Peripheral Vascular Diseases Historic and Forecast Sales By Regions
• 6.8. Neurological Diseases Historic and Forecast Sales By Regions
• 6.9. Cerebral Aneurysm Historic and Forecast Sales By Regions
• 6.10. Cerebral Arteriovenous Malformations and Fistulas Historic and Forecast Sales By Regions
• 6.11. Gastrointestinal Disorders Historic and Forecast Sales By Regions
• 6.12. Urological and Nephrological Disorders Historic and Forecast Sales By Regions

7. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY PROCEDURE ANALYSIS

• 7.1. Overview By Procedure Analysis
• 7.2. Historical and Forecast Data Analysis By Procedure Analysis
• 7.3. Transcatheter Arterial Embolization Historic and Forecast Sales By Regions
• 7.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Historic and Forecast Sales By Regions
• 7.5. Transarterial Chemoembolization Historic and Forecast Sales By Regions

8. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY END USER ANALYSIS

• 8.1. Overview By End User Analysis
• 8.2. Historical and Forecast Data Analysis By End User Analysis
• 8.3. Hospitals and Clinics Historic and Forecast Sales By Regions
• 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 8.5. Other End Users Historic and Forecast Sales By Regions

9. GLOBAL EMBOLOTHERAPY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLOTHERAPY COMPANIES

• 10.1. Embolotherapy Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF EMBOLOTHERAPY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Merit Medical Systems
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Boston Scientific Corporation
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Medtronic Plc
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Meril Life Sciences Pvt. Ltd
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies